Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology

Author:

Turner Oliver C.1ORCID,Aeffner Famke2,Bangari Dinesh S.3,High Wanda4,Knight Brian5,Forest Tom6,Cossic Brieuc7,Himmel Lauren E.8,Rudmann Daniel G.9ORCID,Bawa Bhupinder10,Muthuswamy Anantharaman11,Aina Olulanu H.11,Edmondson Elijah F.12ORCID,Saravanan Chandrassegar13,Brown Danielle L.14ORCID,Sing Tobias15,Sebastian Manu M.16

Affiliation:

1. Novartis, Novartis Institutes for Biomedical Research, Preclinical Safety, East Hanover, NJ, USA

2. Amgen Inc, Research, Comparative Biology and Safety Sciences, San Francisco, CA, USA

3. Sanofi, Global Discovery Pathology, Framingham, MA, USA

4. High Preclinical Pathology Consulting, Rochester, NY, USA

5. Boehringer Ingelheim Pharmaceuticals Incorporated, Nonclinical Drug Safety, Ridgefield, CT, USA

6. Merck & Co, Inc, West Point, PA, USA

7. Roche, Pharmaceutical Research and Early Development (pRED), Roche Innovation Center, Basel, Switzerland

8. Division of Animal Care, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA

9. Charles River Laboratories, Pathology, Ashland, OH, USA

10. AbbVie, Preclinical Safety, North Chicago, IL, USA

11. Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA

12. Pathology/Histotechnology Laboratory, Frederick National Laboratory for Cancer Research, NIH, Frederick, MD, USA

13. Novartis, Novartis Institutes for Biomedical Research, Preclinical Safety, Cambridge, MA, USA

14. Charles River Laboratories, Durham, NC, USA

15. Novartis, Novartis Institutes for Biomedical Research, NIBR Informatics, Basel, Switzerland

16. Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, USA

Abstract

Toxicologic pathology is transitioning from analog to digital methods. This transition seems inevitable due to a host of ongoing social and medical technological forces. Of these, artificial intelligence (AI) and in particular machine learning (ML) are globally disruptive, rapidly growing sectors of technology whose impact on the long-established field of histopathology is quickly being realized. The development of increasing numbers of algorithms, peering ever deeper into the histopathological space, has demonstrated to the scientific community that AI pathology platforms are now poised to truly impact the future of precision and personalized medicine. However, as with all great technological advances, there are implementation and adoption challenges. This review aims to define common and relevant AI and ML terminology, describe data generation and interpretation, outline current and potential future business cases, discuss validation and regulatory hurdles, and most importantly, propose how overcoming the challenges of this burgeoning technology may shape toxicologic pathology for years to come, enabling pathologists to contribute even more effectively to answering scientific questions and solving global health issues. [Box: see text]

Publisher

SAGE Publications

Subject

Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine

Reference200 articles.

1. Accenture. Unleashing AI Power. 2019. https://www.accenture.com/us-en/insight-ai-industry-growth. Accessed April 5, 2019.

2. Sundar A. How AI is changing the world as we know it! Digital Doughnut. 2018. https://www.digitaldoughnut.com/articles/2018/july/how-ai-is-changing-the-world-as-we-know-it. Accessed May 24, 2019.

3. Davenport T, Dreyer K. AI will change radiology, but it won’t replace radiologists. Harvard Business Review; 2018. https://hbr.org/2018/03/ai-will-change-radiology-but-it-wont-replace-radiologists. Accessed October 2, 2019.

4. Wu N, Phang J, Park J, et al. Deep neural networks improve radiologists’ performance in breast cancer screening. 2019. https://arxiv.org/abs/1903.08297v1. Accessed May 30, 2019.

5. A survey on deep learning in medical image analysis

Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3